Zielinski C - Search Results

1

Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.

Horak P, Pils D, Haller G, Pribill I, Roessler M, Tomek S, Horvat R, Zeillinger R, Zielinski C, Krainer M. Horak P, et al. Among authors: zielinski c. Mol Cancer Res. 2005 Jun;3(6):335-43. doi: 10.1158/1541-7786.MCR-04-0136. Mol Cancer Res. 2005. PMID: 15972852

2

Impaired production of tumor necrosis factor in breast cancer.

Zielinski CC, Mueller C, Tyl E, Tichatschek E, Kubista E, Spona J. Zielinski CC, et al. Cancer. 1990 Nov 1;66(9):1944-8. doi: 10.1002/1097-0142(19901101)66:9<1944::aid-cncr2820660916>3.0.co;2-w. Cancer. 1990. PMID: 2224791

3

Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease.

Krainer M, Wolf H, Michl I, Wiltschke C, Budinsky A, Kaider A, Kratzik C, Eibl MM, Zielinski CC. Krainer M, et al. Among authors: zielinski cc. Cancer. 1995 Jan 15;75(2):539-44. doi: 10.1002/1097-0142(19950115)75:2<539::aid-cncr2820750217>3.0.co;2-4. Cancer. 1995. PMID: 7529130

4

Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.

Wiltschke C, Krainer M, Wagner A, Linkesch W, Zielinski CC. Wiltschke C, et al. Among authors: zielinski cc. Exp Hematol. 1995 May;23(5):402-6. Exp Hematol. 1995. PMID: 7536681 Clinical Trial.

5

In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity.

Wiltschke C, Krainer M, Nanut M, Wagner A, Linkesch W, Zielinski CC. Wiltschke C, et al. Among authors: zielinski cc. J Interferon Cytokine Res. 1995 Mar;15(3):249-53. doi: 10.1089/jir.1995.15.249. J Interferon Cytokine Res. 1995. PMID: 7584671

6

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

Wiltschke C, Krainer M, Budinsky AC, Berger A, Müller C, Zeillinger R, Speiser P, Kubista E, Eibl M, Zielinski CC. Wiltschke C, et al. Among authors: zielinski cc. Br J Cancer. 1995 Jun;71(6):1292-6. doi: 10.1038/bjc.1995.250. Br J Cancer. 1995. PMID: 7779726 Free PMC article.

7

Failure to confirm presence of SV40 sequences in human tumours.

Krainer M, Schenk T, Zielinski CC, Müller C. Krainer M, et al. Among authors: zielinski cc. Eur J Cancer. 1995 Oct;31A(11):1893. doi: 10.1016/0959-8049(95)00284-p. Eur J Cancer. 1995. PMID: 8541126 No abstract available.

8

Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro.

Budinsky AC, Brodowicz T, Wiltschke C, Czerwenka K, Michl I, Krainer M, Zielinski CC. Budinsky AC, et al. Among authors: zielinski cc. Int J Cancer. 1997 Jun 11;71(6):1086-90. doi: 10.1002/(sici)1097-0215(19970611)71:6<1086::aid-ijc27>3.0.co;2-a. Int J Cancer. 1997. PMID: 9185715

9

Tissue expression and serum levels of HER-2/neu in patients with breast cancer.

Krainer M, Brodowicz T, Zeillinger R, Wiltschke C, Scholten C, Seifert M, Kubista E, Zielinski CC. Krainer M, et al. Among authors: zielinski cc. Oncology. 1997 Nov-Dec;54(6):475-81. doi: 10.1159/000227606. Oncology. 1997. PMID: 9394844

10

Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro.

Brodowicz T, Wiltschke C, Budinsky AC, Krainer M, Steger GG, Zielinski CC. Brodowicz T, et al. Among authors: zielinski cc. Int J Cancer. 1997 Dec 10;73(6):875-9. doi: 10.1002/(sici)1097-0215(19971210)73:6<875::aid-ijc19>3.0.co;2-3. Int J Cancer. 1997. PMID: 9399669

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

908 results

Search Page

Filters